Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Roca

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Medicina Clinica|May 24, 2025
Predictive value of bicarbonate levels at admission for severe hypoxic-ischemic encephalopathy after out-of-hospital cardiac arrestMarc Izquierdo Ribas, Teresa López-Sobrino, Eva Moreno, et al.
Journal of Medicinal Chemistry|May 27, 2017
Subtly Modulating Glycogen Synthase Kinase 3 β: Allosteric Inhibitor Development and Their Potential for the Treatment of Chronic DiseasesValle Palomo, Daniel I Perez, Carlos Roca, et al.
Critical Care (London, England)|May 19, 2026
Impact of extracorporeal membrane oxygenation on antimicrobial exposure in critically ill patients: a prospective observational studyAlba Escolà-Rodríguez, Elena Sandoval, Raúl Rigo-Bonnin, et al.
European Journal of Medicinal Chemistry|September 2, 2017
From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's diseaseTalita P C Chierrito, Susimaire Pedersoli-Mantoani, Carlos Roca, et al.
Journal of Medicinal Chemistry|August 7, 2018
Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation InhibitorsAnnachiara Gandini, Manuela Bartolini, Daniele Tedesco, et al.
Heart, Lung & Circulation|October 18, 2025
Evolution and Contemporary Predictors of Outcomes in Out-of-Hospital Cardiac Arrest Patients Admitted to Intensive Cardiovascular Care Units: The Multicentric PCR-Cat RegistryRut Andrea, Marc Izquierdo-Ribas, Esther Sanz, et al.
Journal of Medicinal Chemistry|December 26, 2023
Optimization of Selectivity and Pharmacokinetic Properties of Salt-Inducible Kinase Inhibitors that Led to the Discovery of Pan-SIK Inhibitor GLPG3312Taouès Temal-Laib, Christophe Peixoto, Nicolas Desroy, et al.
Journal of Medicinal Chemistry|March 29, 2024
Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory DiseasesChristophe Peixoto, Agnes Joncour, Taouès Temal-Laib, et al.
Cancer Biology & Therapy|May 8, 2010
Nimotuzumab plus radiotherapy for unresectable squamous-cell carcinoma of the head and neckMarta Osorio Rodríguez, Teresa Cruz Rivero, Ramón del Castillo Bahi, et al.
Elife|September 9, 2024
Allosteric modulation of the CXCR4:CXCL12 axis by targeting receptor nanoclustering via the TMV-TMVI domainEva M García-Cuesta, Pablo Martínez, Karthik Selvaraju, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Medicina Clinica|May 24, 2025
Predictive value of bicarbonate levels at admission for severe hypoxic-ischemic encephalopathy after out-of-hospital cardiac arrestMarc Izquierdo Ribas, Teresa López-Sobrino, Eva Moreno, et al.
Journal of Medicinal Chemistry|May 27, 2017
Subtly Modulating Glycogen Synthase Kinase 3 β: Allosteric Inhibitor Development and Their Potential for the Treatment of Chronic DiseasesValle Palomo, Daniel I Perez, Carlos Roca, et al.
Critical Care (London, England)|May 19, 2026
Impact of extracorporeal membrane oxygenation on antimicrobial exposure in critically ill patients: a prospective observational studyAlba Escolà-Rodríguez, Elena Sandoval, Raúl Rigo-Bonnin, et al.
European Journal of Medicinal Chemistry|September 2, 2017
From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's diseaseTalita P C Chierrito, Susimaire Pedersoli-Mantoani, Carlos Roca, et al.
Journal of Medicinal Chemistry|August 7, 2018
Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation InhibitorsAnnachiara Gandini, Manuela Bartolini, Daniele Tedesco, et al.
Heart, Lung & Circulation|October 18, 2025
Evolution and Contemporary Predictors of Outcomes in Out-of-Hospital Cardiac Arrest Patients Admitted to Intensive Cardiovascular Care Units: The Multicentric PCR-Cat RegistryRut Andrea, Marc Izquierdo-Ribas, Esther Sanz, et al.
Journal of Medicinal Chemistry|December 26, 2023
Optimization of Selectivity and Pharmacokinetic Properties of Salt-Inducible Kinase Inhibitors that Led to the Discovery of Pan-SIK Inhibitor GLPG3312Taouès Temal-Laib, Christophe Peixoto, Nicolas Desroy, et al.
Journal of Medicinal Chemistry|March 29, 2024
Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory DiseasesChristophe Peixoto, Agnes Joncour, Taouès Temal-Laib, et al.
Cancer Biology & Therapy|May 8, 2010
Nimotuzumab plus radiotherapy for unresectable squamous-cell carcinoma of the head and neckMarta Osorio Rodríguez, Teresa Cruz Rivero, Ramón del Castillo Bahi, et al.
Elife|September 9, 2024
Allosteric modulation of the CXCR4:CXCL12 axis by targeting receptor nanoclustering via the TMV-TMVI domainEva M García-Cuesta, Pablo Martínez, Karthik Selvaraju, et al.
Pageof 4